Profiles

Robert J. Lefkowitz

James B. Duke Professor of Medicine, Biochemistry, Chemistry; HHMI, Duke University

Verified email at receptor-biol.duke.edu

Cited by 206775

GPCRs Structural biology Biochemistry Arrestins Drug discovery

Marc G. Caron

James B. Duke Professor, Cell Biology, Medicine, Neurobiology Duke University

Verified email at duke.edu

Cited by 146800

GPCR Signaling Psychiatric Disorders Addiction Drug Discovery

Paul IW de Bakker

Vertex Pharmaceuticals

Verified email at vrtx.com

Cited by 131162

human genetics computational genomics structural biology drug discovery bioinformatics

Michael P. Lisanti, MD-PhD, FRSA, FRSB, FRSC

Professor and Chair of Translational Medicine, University of Salford (Greater Manchester)

Verified email at salford.ac.uk

Cited by 119731

Senescence Mitochondria Cancer Stem Cells Breast Cancer Drug Discovery

Ashish Awasthi

CSIR-Central Drug Research Institute (CDRI)

Verified email at cdri.res.in

Cited by 106495

Biostatistics Public Health Drug Discovery

Wei Li

University of Tennessee Health Science Center

Verified email at uthsc.edu

Cited by 93514

drug discovery medicinal chemistry cancer neurodegenerative diseases analytical chemistry including NMR UPLC�…

Philip E. Bourne

University of Virginia

Verified email at virginia.edu

Cited by 89117

Data Science Computational Biology Drug Discovery Scholarly Communication Professional

Oliver Kepp

INSERM UMR1138 / Gustave Roussy Cancer Center

Verified email at gustaveroussy.fr

Cited by 78227

Anticancer immunotherapy Drug discovery

Tom L Blundell

Emeritus Professor of Biochemistry, University of Cambridge

Verified email at cam.ac.uk

Cited by 77218

Structural biology Bioinformatics Biochemistry Drug Discovery

James Bradner

Novartis Institutes for BioMedical Research

Verified email at novartis.com

Cited by 69610

Chemical Biology Chromatin Biology Cancer Biology Targeted Protein Degradation Drug Discovery

1 - 10